(Q45140677)

10 December 2017

1 reference

title

Helicobacter pylori and nonmalignant diseases (English)

1 reference

10 December 2017

1 reference

2

Peter Malfertheiner

1 reference

10 December 2017

1

Ernst J Kuipers

1 reference

10 December 2017

language of work or name

1 reference

1 January 2004

1 reference

10 December 2017

1 reference

10 December 2017

volume

9 Suppl 1

1 reference

10 December 2017

page(s)

29-34

1 reference

Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

DNA-level characterization of Helicobacter pylori strains from patients with overt disease and with benign infections in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Helicobacter pylori infection treatment of nonulcer dyspepsia: an analysis of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Cost-effectiveness of alternative approaches in the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Approach to treatment of dyspepsia in primary care: a randomized trial comparing "test-and-treat" with prompt endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Helicobacter pylori genotypes and expression of gastritis in erosive gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Plasma ghrelin following cure of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00247.X

Initial management strategies for dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001961

Eradication of Helicobacter pylori for non-ulcer dyspepsia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002096

Identifiers

DOI

10.1111/J.1083-4389.2004.00247.X

1 reference

10 December 2017

1 reference